INTRODUCTION
============

Diabetes mellitus remains the leading cause of blindness among working age Americans with diabetic macular edema (DME) being the most common cause for moderate and severe vision loss \[[@R1]-[@R3]\]. The use of anti-vascular endothelial grow factor (anti-vegf) medications has become the first line treatment for DME \[[@R4]-[@R9]\] with macular laser and steroids as adjuvant agents for non-responders \[[@R10]-[@R14]\]. Despite these improvements there is no standardized approach for the treatment of chronic or recurrent DME and repeated intraocular injections pose a significant burden on patients, physicians and the healthcare system.

Pars plana vitrectomy (PPV) has been suggested as a potential alternative to intravitreal injections and macular laser. Multiple studies showed reduction in central macular thickness (CMT) and visual gains in patients with abnormalities of the vitreo-retinal interface \[[@R15]-[@R19]\]. More recently several papers evaluated the effects of PPV with or without internal limiting membrane (ILM) peeling in patients with nontractional DME and reported mixed effects. While some authors reported postoperative anatomic and visual improvements \[[@R20]-[@R23]\] others did not confirm gains in visual acuity \[[@R24]-[@R28]\].

In two publications the authors preoperatively examined the status of the outer retinal layers on spectral domain OCT (sdOCT) and reported visual gains after PPV with ILM peel in patients with preserved external limiting membrane and ellipsoid zone (EZ) retinal layers \[[@R29], [@R30]\].

Due to the heterogeneity of study designs it remains unclear to this day which patients would benefit from PPV with ILM peeling for DME.

In this study we evaluated if PPV with ILM peeling could reduce the CMT and improve visual acuity in patients with nontractional DME as well as the predictive value of preoperative sdOCT.

MATERIAL AND METHODS
====================

We retrospectively reviewed the medical records of all consecutive patients undergoing PPV with ILM peeling for DME at our institution from 2012 to 2014.

We excluded patients with less than 6 month follow up or worse than 20/400 vision preoperatively, patients with abnormalities of the vitreo-retinal interface on sdOCT and patients who had received any treatment for DME within 3 months prior to vitrectomy. We also excluded patients who had received adjuvant intraoperative or postoperative steroid or anti-vegf injections.

All patients had undergone standard 25-gauge vitrectomy with peribulbar anesthesia by a single surgeon. After induction of a posterior vitreous detachment, indocyanine green (ICG) assisted ILM peeling of an area of at least three disc diameters centered on the fovea was achieved.

Patients had Heidelberg sdOCT images of the macula on the pre- and each postoperative visit (Heidelberg Engineering, Heidelberg, Germany). We evaluated OCT images for the presence of abnormalities of the vitreo-retinal interface and determined the status of the external limiting membrane (ELM) and ellipsoid zone (EZ) in the foveal area as preserved or disrupted/abnormal (Fig. **[1](#F1){ref-type="fig"}**).

Phakic status, prior number of intravitreal injections and focal/grid laser were recorded.

Visual acuity and central macular thickness were evaluated preoperatively as well as 1 month, 3 months and 6 months after the surgery. In a subgroup analysis patients with intact ELM/EZ were compared with patients with abnormal foveal anatomy and analyzed in regards to different outcome.

Pre- and postoperative data was compared using the student t-test. A p-value smaller than 0.05 was considered statistically significant.

All research adhered to the tenets of the Declaration of Helsinki and the Internal Review Board of our University had approved the study protocol.

RESULTS
=======

We identified 42 eyes in the database and eventually included 31 eyes of 28 patients. Average age was 63 years, 17 out of 31 eyes (55%) belonged to male patients (Table **[1](#T1){ref-type="table"}**). The average preoperative CMT was 427 microns, mean visual acuity 20/82. 10 patients (32%) had an intact ELM and ellipsoid zone in the foveal area.

At 1 and 3 months postoperatively, there was no significant change in either CMT (431, 390 microns; p= 0.91, 0.29) or visual acuity (20/73, 20/60; p= 0.69, 0.21). However at 6 months postoperatively the central macular thickness had significantly decreased (357 microns; p=0.03) and the visual acuity was improved (20/49; p=0.03; Table **[2](#T2){ref-type="table"}**). No patient had worsened visual acuity postoperatively and 10 patients (32%) improved by three lines or more.

Patients with intact ELM/EZ had statistically significant better visual acuity preoperatively compared to the patients with defects on OCT (20/54 vs 20/100; p=0.03). Patients with intact foveal anatomy improved to 20/33 at the last visit (p\<0.009) with 6 out of 10 patients (60%) gaining three or more lines of vision. Patients with defects in foveal anatomy improved to 20/81 (p=non-significant) with only 4 patients (20%) improving three or more lines of vision. There was no difference in foveal thickness between the groups with preserved and defective anatomy at any point in the study. (Table **[3](#T3){ref-type="table"}**).

DISCUSSION
==========

Our study was able to demonstrate a statistically significant improvement in visual acuity and decrease in foveal thickness six months after vitrectomy with ILM peel in patients with nontractional DME. The improvement in visual acuity was even more pronounced in patients with preserved foveal anatomy on sdOCT.

While the current literature appears to support vitrectomy for tractional DME \[[@R15]-[@R19]\], the benefit of PPV in patients with nontractional DME is much less clear. It is believed that vitrectomy can reduce DME by increasing the oxygenation in the vitreous cavity and removing proangiogenic factors like VEGF as well as cytokines and chemokines which promote a breakdown of the blood retinal barrier \[[@R31]-[@R33]\]. The role of ILM peeling during surgery remains unclear as well. In patients without obvious abnormalities of the vitreo-retina interface, peeling of the ILM can ensure that no residual vitreous is left behind and can reduce tangential traction \[[@R34], [@R35]\].

Kumagai *et al*. reported visual gains in two large series of patients with nontractional diabetic macular edema with or without ILM peeling. In these studies the macular anatomy was not assessed with sdOCT and all phakic patients underwent simultaneous cataract extraction which may have contributed to visual gains \[[@R36], [@R37]\]. However, several studies were unable to demonstrate visual gains despite anatomical improvement \[[@R24]-[@R28]\].

Two authors recently reported an association between photoreceptor damage represented by disruption of the outer retina on sdOCT and visual acuity in patients DME. Chabblani's *et al*. group retrospectively studied 34 eyes with resistant DME and found pre-operative ELM integrity to be a better predictor for vision improvement than CMT or IS/OS junction integrity. While combining ELM integrity and preoperative CMT yielded the best predictive information, the addition of the IS/OS junction integrity was not beneficial. This study included patients with abnormalities of the vitreo-retinal interface (*e.g*. epiretinal membrane) which complicates a direct comparison to our study of nontractional DME \[[@R29]\]. Nishijama *et al*. reported on sdOCT findings and visual outcomes in a retrospective series of 32 eyes. Ten of these eyes were found to have what is described as "hyperreflective foci" in the outer retinal layers. While it remains unclear what exactly these foci represent, they appeared to be associated with damage to the IS/OS junction and worse visual outcome after vitrectomy \[[@R30]\].

In a recent retrospective study of 53 eyes, Browning *et al*. reported improved foveal thickness and visual acuity 12 months after vitrectomy for DME. The intactness of the EZ on sdOCT did not appear to be correlated with better postoperative vision. This study included patients with abnormalities of the vitreo-retinal interface, patients with proliferative diabetic retinopathy. Further, intravitreal steroids were injected in a majority of cases at the end of the surgery \[[@R38]\].

Due to significant heterogeneity among these studies including inclusion criteria, surgical technique and follow up, the visual benefit of PPV in patients with nontractional DME remains unclear.

Our study is limited by the small numbers and its retrospective nature. However, we were able to demonstrate visual and anatomical benefits in patients undergoing vitrectomy with ILM peeling for nontractional DME and suggest the integrity of the outer retina on sdOCT as possible predictor for visual potential.

Larger prospective studies may give additional insight into which patients will benefit the most from vitrectomy as well as the optimal time of surgical intervention.
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###### 

Baseline characteristics.

                                      N=31
  ----------------------------------- ---------
  Age (mean in years)                 63
  Male (%)                            17 (55)
  Number of prior injections (mean)   5
  Prior focal/grid laser (%)          19 (61)
  Pseudophakia (%)                    11 (35)
  Intact ELM and EZ (%)               10 (32)
  Preoperative CMT (mean/microns)     427
  Preoperative visual acuity (mean)   20/82

ELM- External limiting membrane, EZ- ellipsoid zone.

###### 

Changes in central macular thickness and visual acuity over course of study.

  N=31                 Preop   1 mos postop   3 mos postop   6 mos postop   P value (6-mos)
  -------------------- ------- -------------- -------------- -------------- -----------------
  CMT (mean/microns)   427     431            390            357            0.03
  VA                   20/82   20/73          20/60          20/49          0.03

CMT- central macular thickness, VA- visual acuity.

###### 

Change in central macular thickness and visual acuity in patients with intact versus irregular outer retinal anatomy.

  -------------------- -------------------------- --------------------------------- --------- ----------------------------- ------------------------------------ ---------
                       Intact ELM/EZ Preop N=10   Intact ELM/EZ 6 mos postop N=10   P value   Irregular ELM/EZ Preop N=21   Irregular ELM/EZ 6 mos postop N=21   P value
  CMT (mean/microns)   407                        368                               ns        453                           350                                  ns
  VA                   20/54                      20/33                             0.009     20/100                        20/81                                ns
  -------------------- -------------------------- --------------------------------- --------- ----------------------------- ------------------------------------ ---------

ELM- External limiting membrane, EZ- ellipsoid zone, CMT- central macular thickness, VA- visual acuity, ns = non-significant.
